EWTX

Edgewise Therapeutics Stock Analysis

AI Rating

Fair
  • Quality2/10
  • Growth↓ 0/10
  • Value↑ 6/10
Edgewise Therapeutics sales and earnings growth
EWTX Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -7.74%
  • FCF Y/Y↓ -24.81%
Edgewise Therapeutics gross and profit margin trends
EWTX Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -32.15%
Edgewise Therapeutics net debt vs free cash flow
EWTX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Edgewise Therapeutics stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks